1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Cell and Gene Therapy (CGT) Access Model is sponsored by Department of Health And Human Services. The Cell and Gene Therapy (CGT) Access Model aims to improve the lives of people with Medicaid living with rare and severe diseases by increasing access to potentially transformative treatments. It is a multi-year, voluntary model for states and manufacturers to test whether a CMS-led approach to developing and administering outcomes-based agreements (OBAs) for cell and gene therapies increases Medicaid beneficiaries’ access to innovative treatment, improves their health outcomes, and reduces health care costs and burden to state Medicaid programs. The initial focus of the model is on access to gene therapy treatments for people living with sickle cell disease, a genetic blood disorder. Manufacturers and state participants joined the model through a Request for Application (RFA) process. States begin participation between January 2025 and January 2026.
The Notice of Funding Opportunity (NOFO) announced the opportunity to apply for Cooperative Agreement funding to support states’ participation in the CGT Access Model. Cooperative Agreement funding is intended to support state model implementation activities and to support states that take steps to improve equitable access to gene therapy and multi-disciplinary, comprehensive care in conjunction with the model test. This listing is currently active. Program number: 93.885. Last updated on 2026-01-15.
Get alerted about grants like this
Save a search for “Department of Health And Human Services” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Eligible applicants are States, the District of Columbia, and any U.S. Territory participating in the Medicaid Drug Rebate Program (MDRP). Eligible applicants must: • Apply to the State Request for Applications (RFA) by no later than March 14, 2025 • Apply to the Notice of Funding Opportunity (NOFO) by no later than March 14, 2025 • Sign a State Agreement with CMS by no later than June 1, 2025 Eligible applicant types include: U.S. State Government (including the District of Columbia), U.S. Territory (or Possession) Government (including freely-associated states), State. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Recent federal obligations suggest $5,332,710 (2026). Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Implementing Zero Suicide in Health Systems is sponsored by Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services. Implements the comprehensive Zero Suicide intervention and prevention model for adults within health systems. Requires application of seven framework elements: Lead, Train, Identify, Engage, Treat, Transition, and Improve.
Utah Primary Care Grant Program is a grant from the Utah Department of Health and Human Services – Office of Primary Care and Rural Health that funds organizations providing primary healthcare to medically underserved and low-income populations across Utah. The program increases access to ambulatory primary care services for low-wage workers, children, the elderly, migrant farmworkers, and the uninsured or underinsured. Eligible applicants include private non-profit and public organizations delivering primary healthcare in Utah. The 2026 application cycle opened March 9 and closed March 31, 2026, with an application orientation held on March 17.
Utah Primary Care Grant Program is a grant from the Utah Department of Health and Human Services Office of Primary Care and Rural Health that funds organizations providing primary healthcare to medically underserved populations in Utah. The program supports ambulatory primary care services for low-income, uninsured, and underinsured individuals — including workers with low wages, families without health insurance ineligible for Medicaid or CHIP, and patients needing services not covered by existing insurance. Objectives include improving health outcomes, ensuring care continuity, and expanding organizational capacity to serve target populations. Eligible applicants are private nonprofit and public organizations in Utah providing primary healthcare. The 2026 application cycle closed March 31, 2026.